Inconclusive Bone Scan in Men with Intermediate and High-risk Prostate Cancer: What next?


Journal

Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 23 7 2020
medline: 12 10 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

To evaluate the incidence of inconclusive bone scans and down-stream imaging and clinical follow-up generated, including subsequent treatment outcomes in men affected by inconclusive bone scans with intermediate- and high-risk prostate cancer. Retrospective study of clinical data for a Scottish population of men diagnosed with prostate cancer in the intermediate and high-risk groups. Of the 1,246 patients included, initially 81 men were identified as having an inconclusive bone scan result following multidisciplinary team discussion. After further imaging, 24 patients remained inconclusive for metastasis. Of these, two patients received no treatment; one because of a watchful waiting decision, and one because of death. Of the 13 patients receiving radical treatment (laparoscopic radical prostatectomy or radiotherapy), three patients showed relapse (23%) indicating presence of microscopic disease and failure of radical treatment alone for these patients. This paper will assist nurses and multidisciplinary team members in understanding how patients diagnosed with intermediate- and high-risk prostate cancer with inconclusive bone scan results are subsequently imaged and managed in the current health care system. This raises awareness amongst nursing staff of disease recurrence and the possibility of downstream multimodality treatment for these men with inconclusive bone scans.

Identifiants

pubmed: 32693961
pii: S0749-2081(20)30061-9
doi: 10.1016/j.soncn.2020.151046
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151046

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Charlotte Primeau (C)

School of Medicine, Division of Cancer, University of Dundee, Ninewells Hospital, Dundee, Scotland, UK. Electronic address: Charlieprimeau@gmail.com.

Catherine Paterson (C)

Faculty of Health, University of Canberra, Canberra ACT, Australia; Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research group, University of Canberra, Canberra ACT, Australia; School of Nursing, Midwifery and Public Health, University of Canberra, ACT, Australia; ACT Health Synergy Nursing and Midwifery Research Centre, Canberra Hospital, ACT, Australia; Robert Gordon University, Aberdeen, Scotland, UK.

Ghulam Nabi (G)

School of Medicine, Division of Cancer, University of Dundee, Ninewells Hospital, Dundee, Scotland, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH